Atricure Inc(ATRC) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
September 11 at 4:39 AM ET (Korea 9/11 17:39)
Full metrics table
| Index | RUT | P/E | 244.85 | EPS (ttm) | 0.22 | Insider Own | 4.04% | Shs Outstand | 50.9M | Perf Week | 0.8% |
| Market Cap | 2.70B | Forward P/E | 126.62 | EPS next Y | 291.48% | Insider Trans | -3.66% | Shs Float | 48.8M | Perf Month | 23.42% |
| Enterprise Value | 2.60B | PEG | - | EPS next Q | -0.04 | Inst Own | 104.92% | Short Float | 8.04% | Perf Quarter | 92.69% |
| Income | 0.01B | P/S | 4.73 | EPS this Y | 144.56% | Inst Trans | 4.44% | Short Ratio | 4.18 | Perf Half Y | 77.53% |
| Sales | 0.57B | P/B | 5.22 | EPS next 5Y | - | ROA | 1.64% | Short Interest | 3.92M | Perf YTD | 34% |
| Book/sh | 10.15 | P/C | 16.07 | EPS past 3/5Y | 38.2% 26.83% | ROE | 2.15% | 52W High | -4.86% ($55.72) | Perf Year | 50.81% |
| Cash/sh | 3.3 | P/FCF | 50.77 | Sales past 3/5Y | 17.4% 20.95% | ROIC | 1.8% | 52W Low | 109.03% ($25.36) | Perf 3Y | 27.4% |
| Dividend Est. | - | EV/EBITDA | 74.9 | EPS Y/Y TTM | 128.25% | Gross Margin | 75.77% | Volatility(W/M) | 4.97% 4.06% | Perf 5Y | -29.02% |
| Dividend TTM | - | EV/Sales | 4.57 | Sales Y/Y TTM | 13.94% | Oper. Margin | 2.44% | ATR (14) | 2.01 | Perf 10Y | 228.64% |
| Dividend Ex-Date | - | Quick Ratio | 3.19 | EPS Q/Q | 241.25% | Profit Margin | 1.85% | RSI (14) | 74.14 | Recom | 1.4 |
| Dividend Gr. 3/5Y | - | Current Ratio | 4.22 | Sales Q/Q | 12.83% | SMA20 | 8.19% ($49) | Beta | 1.26 | Target Price | $51.67 |
| Payout | - | Debt/Eq | 0.14 | Earnings | 2026/7/23 | SMA50 | 27.66% ($41.52) | Rel Volume | 1.02 | Prev Close | $53.03 |
| Employees | 1350 | LT Debt/Eq | 0.14 | EPS/Sales Surpr. | 10688.24% 1.19% | SMA200 | 52.24% ($34.82) | Avg Volume(3M) | 0.94M | Price | $53.01 |
| IPO | 2005/8/5 | Option/Short | Yes/Yes | Trades | 13490 | Volume | 960,315 | Change | -0.04% |
Company
ATRC is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
🫀 AtriCure (ATRC) is a US medical device company specializing in surgical treatment for atrial fibrillation (Afib), left atrial appendage management, and post-operative pain management. Focused on surgical ablation, the company supplies its clamp and device product lines to cardiac surgery centers through a direct sales network and distribution partners, building a differentiated position in the niche field of arrhythmia treatment as an innovation-driven medtech company.
Over the past 1 year, on the higher side
5% below its 1-year high.
ATRC makes money exceptionally well
Strong earnings and excellent financial health
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +144.6% this year.
Tap to view numbers
But it is not cheap
Trading at 244.8 times earnings.
Tap to view numbers
It has beaten expectations every time
Beat market estimates in the last 3 quarters.
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Strong Buy.
Tap to view numbers
Holding long would have lost money
Would have changed by +27.4% if bought 5 years ago.
Tap to view numbers
Dividends are hard to expect
This stock does not pay dividends
Ownership looks stable
Institutions hold 104.9%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
XHE 0.02%
HAPS 0.01%
APPC 0.01%
AIMS 0.01%
QQQS 0.00%It ranks #4 in the industry
Based on market cap of $3B.
ATRC $3B PER 244.8
ISRG $127B PER 41.3
BDX $48B PER 53.2
MDLN $43B PER 38.0
FAQ
What kind of company is ATRC?
ATRC belongs to the Healthcare sector and operates in the Medical Instruments & Supplies industry.
What is the market cap of ATRC?
The market cap of ATRC is approximately $2.7B, ranking 1,864 within its sector.
What is the P/E ratio of ATRC?
ATRC has a P/E ratio of approximately 244.8x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for ATRC?
ATRC has recorded a 52-week high of $55.72 and a low of $25.36.
